PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
1.690
-0.020 (-1.17%)
At close: Jun 26, 2026, 4:00 PM EDT
1.700
+0.010 (0.59%)
After-hours: Jun 26, 2026, 4:04 PM EDT
PepGen Employees
PepGen had 59 employees as of March 31, 2026. The number of employees decreased by 20 or -25.32% compared to the same quarter last year.
Employees
59
Change
-20
Growth
-25.32%
Revenue / Employee
n/a
Profits / Employee
-$1,308,746
Market Cap
116.90M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 59 | -20 | -25.32% |
| Dec 31, 2025 | 56 | -25 | -30.86% |
| Sep 30, 2025 | 57 | -19 | -25.00% |
| Jun 30, 2025 | 62 | -10 | -13.89% |
| Mar 31, 2025 | 79 | 14 | 21.54% |
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Sep 30, 2024 | 76 | 13 | 20.63% |
| Jun 30, 2024 | 72 | 18 | 33.33% |
| Mar 31, 2024 | 65 | 16 | 32.65% |
| Dec 31, 2023 | 64 | 19 | 42.22% |
| Sep 30, 2023 | 63 | 23 | 57.50% |
| Jun 30, 2023 | 54 | 18 | 50.00% |
| Mar 31, 2023 | 49 | 18 | 58.06% |
| Dec 31, 2022 | 45 | 14 | 45.16% |
| Sep 30, 2022 | 40 | 17 | 73.91% |
| Jun 30, 2022 | 36 | 24 | 200.00% |
| Mar 31, 2022 | 31 | 19 | 158.33% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fractyl Health | 100 |
| enGene Therapeutics | 82 |
| Agenus | 81 |
| Aardvark Therapeutics | 40 |
| Oncolytics Biotech | 29 |
| Genelux | 26 |
| Spero Therapeutics | 25 |
| Coya Therapeutics | 8 |
PEPG News
- 10 days ago - Craig-Hallum bullish on PepGen, initiates with a Buy - TheFly
- 10 days ago - PepGen initiated with a Buy at Craig-Hallum - TheFly
- 5 weeks ago - PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program - Business Wire
- 5 weeks ago - PepGen files $400M mixed securities shelf - TheFly
- 5 weeks ago - PepGen Registration statement: Registration filing - Filings
- 6 weeks ago - PepGen price target lowered to $4 from $5 at Wedbush - TheFly
- 6 weeks ago - PepGen reports Q1 EPS (26c), consensus (31c) - TheFly
- 6 weeks ago - PepGen sees cash runway into 2H27 - TheFly